Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-03

Clinical Trial Update: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing mycophenolate mofetil to azathioprine for maintenance therapy in lupus nephritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolate mofetil (CellCept) (mycophenolate mofetil)
  • azathioprine (Imuran) (azathioprine)

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED